- Report
- January 2026
- 275 Pages
Global
From €2225EUR$2,500USD£1,922GBP
- Report
- August 2025
- 216 Pages
Global
From €2225EUR$2,500USD£1,922GBP
- Report
- July 2025
- 246 Pages
Global
From €2225EUR$2,500USD£1,922GBP
- Report
- July 2025
- 208 Pages
Global
From €2225EUR$2,500USD£1,922GBP
- Report
- June 2025
- 197 Pages
Global
From €2225EUR$2,500USD£1,922GBP
- Report
- June 2025
- 206 Pages
Global
From €2225EUR$2,500USD£1,922GBP
- Report
- June 2025
- 219 Pages
Global
From €2225EUR$2,500USD£1,922GBP
- Report
- June 2025
- 210 Pages
Global
From €2225EUR$2,500USD£1,922GBP
- Report
- January 2026
- 185 Pages
Global
From €4006EUR$4,500USD£3,460GBP
- Report
- August 2025
- 188 Pages
Global
From €4006EUR$4,500USD£3,460GBP
- Report
- July 2025
- 350 Pages
Global
From €4405EUR$4,949USD£3,805GBP
- Report
- June 2025
- 400 Pages
Global
From €4405EUR$4,949USD£3,805GBP
- Report
- June 2025
- 400 Pages
Global
From €4405EUR$4,949USD£3,805GBP
- Report
- June 2026
- 142 Pages
Global
From €5207EUR$5,850USD£4,498GBP
- Report
- June 2026
- 331 Pages
Global
From €5207EUR$5,850USD£4,498GBP
- Report
- June 2026
- 388 Pages
Global
From €5207EUR$5,850USD£4,498GBP
- Report
- February 2026
- 160 Pages
Global
From €3694EUR$4,150USD£3,191GBP
- Report
- January 2026
- 180 Pages
Global
From €4006EUR$4,500USD£3,460GBP
- Report
- February 2026
- 160 Pages
Global
From €3694EUR$4,150USD£3,191GBP
- Report
- February 2026
- 160 Pages
Global
From €3694EUR$4,150USD£3,191GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more